- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical application of fruquintinib on colorectal cancer
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 12, Issue 8, Pages 713-721
Publisher
Informa UK Limited
Online
2019-06-09
DOI
10.1080/17512433.2019.1630272
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC)
- (2018) Feng Tong et al. Bosnian Journal of Basic Medical Sciences
- Advances in CRC Prevention: Screening and Surveillance
- (2018) Evelien Dekker et al. GASTROENTEROLOGY
- Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
- (2018) Jin Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous Non‒Small-Cell Lung Cancer
- (2018) Shun Lu et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
- (2018) Manuela Porru et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018
- (2018) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Fruquintinib for previously treated metastatic colorectal cancer
- (2018) Talha Khan Burki LANCET ONCOLOGY
- Bevacizumab exacerbates sinusoidal obstruction syndrome (SOS) in the animal model and increases MMP 9 production
- (2018) Azin Jafari et al. Oncotarget
- LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions
- (2018) Cristina Barbagallo et al. Molecular Therapy-Nucleic Acids
- γδ T Cells: Crosstalk Between Microbiota, Chronic Inflammation, and Colorectal Cancer
- (2018) Yunben Yang et al. Frontiers in Immunology
- Evaluation of Colorectal Cancer Incidence Trends in the United States (2000–2014)
- (2018) Benjamin Ansa et al. Journal of Clinical Medicine
- Fruquintinib: First Global Approval
- (2018) Matt Shirley DRUGS
- EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers
- (2018) Mariangela De Robertis et al. Molecular Cancer
- Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
- (2017) Sebastian Stintzing et al. EUROPEAN JOURNAL OF CANCER
- No back seat for a progression event—K-RAS as a therapeutic target in CRC
- (2017) Emily J. Poulin et al. GENES & DEVELOPMENT
- Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
- (2017) Yuji Miyamoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study
- (2017) Rui-Hua Xu et al. Journal of Hematology & Oncology
- Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Colorectal cancer drugs market
- (2017) Sorcha Cassidy et al. NATURE REVIEWS DRUG DISCOVERY
- Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway
- (2017) Guihua Wang et al. Cell Death & Disease
- RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC
- (2017) Xiao-Yan Wang et al. Scientific Reports
- Non–Small Cell Lung Cancer
- (2017) Journal of the National Comprehensive Cancer Network
- Non–Small Cell Lung Cancer
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Personalized Medicine and Oncology Practice Guidelines: A Case Study of Contemporary Biomarkers in Colorectal Cancer
- (2017) Robin K. Kelley et al. Journal of the National Comprehensive Cancer Network
- Non–Small Cell Lung Cancer
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Gut Microbiota, Inflammation, and Colorectal Cancer
- (2016) Caitlin A. Brennan et al. Annual Review of Microbiology
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Phase I study of safety and pharmacokinetics of fruquintinib, a novel selective inhibitor of vascular endothelial growth factor receptor-1, -2, and -3 tyrosine kinases in Chinese patients with advanced solid tumors
- (2016) Junning Cao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- TAS-102 Safety in Metastatic Colorectal Cancer: Results From the First Postmarketing Surveillance Study
- (2016) Takayuki Yoshino et al. Clinical Colorectal Cancer
- Novel anti-angiogenic therapeutic strategies in colorectal cancer
- (2016) M. Tampellini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- The non-small-cell lung cancer drug market
- (2016) Khurram Nawaz et al. NATURE REVIEWS DRUG DISCOVERY
- Cetuximab response in CRC patient-derived xenografts seems predicted by an expression based RAS pathway signature
- (2016) Sheng Guo et al. Oncotarget
- MiR-608, pre-miR-124-1 and pre-miR26a-1 polymorphisms modify susceptibility and recurrence-free survival in surgically resected CRC individuals
- (2016) Hou-Qun Ying et al. Oncotarget
- Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer
- (2016) Suk-young Lee et al. Biomed Research International
- Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy
- (2015) Elena De Mattia et al. DRUG RESISTANCE UPDATES
- Targeted therapies for treatment of non-small cell lung cancer-Recent advances and future perspectives
- (2015) Joan Minguet et al. INTERNATIONAL JOURNAL OF CANCER
- A Case Report of Gastrointestinal Hemorrhage and Perforation During Apatinib Treatment of Gastric Cancer
- (2015) Xiao-Fen Li et al. MEDICINE
- Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
- (2015) Y. Zhao et al. ONCOLOGIST
- KRAS polymorphisms are associated with survival of CRC in Chinese population
- (2015) Qiong Dai et al. TUMOR BIOLOGY
- Inhibition of KRAS codon 12 mutants using a novel DNA-alkylating pyrrole–imidazole polyamide conjugate
- (2015) Kiriko Hiraoka et al. Nature Communications
- Developments in Screening Tests and Strategies for Colorectal Cancer
- (2015) Justin L. Sovich et al. Biomed Research International
- The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC
- (2014) P W Voorneveld et al. BRITISH JOURNAL OF CANCER
- Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy
- (2014) Qiaoling Sun et al. CANCER BIOLOGY & THERAPY
- Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor Fruquintinib (HMPL-013) and the prediction of its human pharmacokinetics
- (2014) Yi Gu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Inflammation and colorectal cancer, when microbiota-host mutualism breaks
- (2014) Marco Candela WORLD JOURNAL OF GASTROENTEROLOGY
- Bioanalysis for plasma protein binding studies in drug discovery and drug development: views and recommendations of the European Bioanalysis Forum
- (2014) Brigitte Buscher et al. Bioanalysis
- Host–microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer
- (2013) Shirin Moossavi et al. Expert Review of Clinical Immunology
- Plasma protein binding: From discovery to development
- (2013) Tonika Bohnert et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
- (2013) Jonathan M. Ostrem et al. NATURE
- Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab
- (2013) Timothy J. Price et al. Cancer Medicine
- Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation and Epigenetics
- (2012) Paolo Garagnani et al. CURRENT PHARMACEUTICAL DESIGN
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Colorectal cancer—driven by inflammation and gut bacteria?
- (2012) Katrina Ray Nature Reviews Gastroenterology & Hepatology
- Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
- (2012) T. Maurer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Basic and Therapeutic Aspects of Angiogenesis
- (2011) Michael Potente et al. CELL
- Oncology Market Research Provides a Feasible Index for Standardization of Colorectal Cancer Chemotherapy
- (2011) Y. Inoue et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?
- (2011) Shankar Balasubramanian et al. NATURE REVIEWS DRUG DISCOVERY
- Plasma Protein Binding in Drug Discovery and Development
- (2010) Monique Howard et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer
- (2010) Thomas Winder et al. GASTROENTEROLOGY
- Advances in the Treatment of Metastatic Colorectal Cancer
- (2009) Carla Kurkjian et al. AMERICAN JOURNAL OF THERAPEUTICS
- Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
- (2009) Fatima Haggar et al. Clinics in Colon and Rectal Surgery
- Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Point
- (2008) N. Arber CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started